米兰系统与IAC-IARC-WHO系统在涎腺软组织及骨肿瘤诊断中的应用:居里研究所经验
该研究回顾性分析1954至2022年间居里研究所2219例涎腺细针穿刺样本,其中86例(3.9%)为软组织及骨肿瘤,63例(73%)有组织学随访。按MSRSGC分类,良恶性判断准确率90.7%,恶性病例检出敏感度95.5%,总体准确率88.3%、敏感度93.6%、特异度82.7%。
要点
- 涎腺软组织及骨肿瘤罕见但可用MSRSGC有效诊断,恶性病例准确率高。
- MSRSGC总体准确率88.3%,敏感度93.6%,特异度82.7%。
- 经典欧洲4级系统、MSRSGC与IAC-IARC-WHO系统的恶性风险度基本一致,良性及不确定类别有微小差异。
核心结论
- 涎腺软组织及骨肿瘤虽罕见,但使用MSRSGC可有效诊断,恶性病例准确率高。
- 经典欧洲系统、MSRSGC与IAC-IARC-WHO系统在恶性风险度上基本一致,良性及不确定类别存在微小差异。
研究设计与样本
- 回顾性分析1954至2022年巴黎居里研究所2219例涎腺细针穿刺样本。
- 86例(3.9%)为软组织及骨肿瘤,其中63例(73%)有组织学随访。
- 细胞学按经典欧洲4级系统、MSRSGC及IAC-IARC-WHO系统分类。
主要发现
- 按MSRSGC分类:8例非肿瘤性、30例良性、1例涎腺肿瘤恶性潜能不确定、5例可疑恶性、42例恶性。
- 良恶性性质准确判断78例(90.7%),组织学-细胞学完全一致51例(59.3%)。
- FNA正确识别44例恶性肿瘤中的42例(95.5%),其中30例(68.2%)诊断完全一致。
- 无病例被归为非诊断性、意义不明的异型性或异型性类别。
关键数值与推荐
- MSRSGC总体准确率88.3%,敏感度93.6%,特异度82.7%。
- 恶性风险度在经典欧洲系统、MSRSGC与IAC-IARC-WHO系统间可比,良性及不确定类别有微小差异。
临床怎么用
- 对涎腺软组织及骨肿瘤的FNA样本可采用MSRSGC进行分类诊断。
- MSRSGC对恶性病例检出敏感度高,有助于临床决策。
局限性
- 仅63例(73%)有组织学随访,存在随访不完整。
- 软组织及骨肿瘤仅占86例(3.9%),样本量有限。
- 三种分类系统间良性及不确定类别的恶性风险度存在微小差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Soft tissue and bone tumors of the salivary gland were compared using classic 4-tier, Milan System for Reporting Salivary Gland Cytopathology (MSRSGC), and the International Academy of Cytology-International Agency for Research on Cancer-World Health Organization (IAC-IARC-WHO) Reporting System for Soft Tissue Cytopathology. METHODS: The authors retrospectively analyzed 2219 salivary gland fine-needle aspiration (FNA) samples collected at the Institut Curie in Paris between 1954 and 2022. A total of 86 cases (3.9%) were identified as soft tissue and bone tumors, with histological follow-up in 63 cases (73%). Cytology was classified according to the classic European 4-tier system, the MSRSGC, and the IAC-IARC-WHO System. RESULTS: According to the MSRSGC, eight cases were classified as nonneoplastic, 30 as benign, one as salivary gland neoplasm of uncertain malignant potential, five as suspicious for malignancy, and 42 as malignant. Benign or malignant nature was accurately assessed in 78 cases (90.7%), with exact histologic-cytologic concordance in 51 cases (59.3%). FNA correctly identified 42 of 44 malignant tumors (95.5%), with exact diagnostic matches in 30 cases (68.2%). The MSRSGC achieved 88.3% overall accuracy, 93.6% sensitivity, and 82.7% specificity. Risk of malignancy (ROM) was comparable for malignant tumors across the classic European system, the MSRSGC, and the IAC-IARC-WHO System, with minor discrepancies observed in benign and indeterminate categories. No cases were assigned as nondiagnostic, atypia of undetermined significance, atypical. CONCLUSIONS: Despite their rarity, soft tissue and bone tumors of the salivary gland can be effectively diagnosed using the MSRSGC, with a high accuracy achieved for malignant cases. Minor discrepancies in ROMs were observed between specific categories of the classic European system, the MSRSGC, and the IAC-IARC-WHO System.
引用
- Kowalewski A, Borowczak J, Brisse HJ, et al. Application of the Milan and IAC-IARC-WHO Systems in diagnosing soft tissue and bone tumors of the salivary glands: The Institut Curie experience. Cancer Cytopathol. 2025. PMID: 40833868. doi:10.1002/cncy.70040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。